Liver Diseases  >>  ITX-5061  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ITX-5061 / iTherX
NCT01560468: Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection

Terminated
1
10
US
ITX 5061
Schiano, Thomas D., MD, iTherX Pharmaceuticals Inc.
Hepatitis C Infection
04/18
04/18

Download Options